Pluristem Therapeutics Inc.
PSTI · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$6,132 | $8,987 | -$6,489 | $719 |
| Dep. & Amort. | $130 | -$936 | $72 | -$118 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $1,350 | -$8,827 | $491 | -$1,907 |
| Change in WC | $0 | $4,609 | $440 | $2,311 |
| Other Non-Cash | -$776 | $14,819 | $1,183 | -$275 |
| Operating Cash Flow | -$5,428 | $18,652 | -$4,303 | $730 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$116 | -$1,522 | -$406 | -$283 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $12,084 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $3,966 | -$10,034 | -$3,826 | $1,850 |
| Investing Cash Flow | $3,850 | $528 | -$4,232 | $1,567 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $2,033 | $9,968 | -$7,500 |
| Financing Cash Flow | $0 | $2,033 | $9,968 | -$7,500 |
| Forex Effect | $1 | -$1,470 | -$453 | -$408 |
| Net Chg. in Cash | -$1,600 | -$17,734 | $1,402 | -$16,640 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $7,196 | $24,930 | $8,290 | $24,930 |
| End Cash | $5,596 | $7,196 | $9,692 | $8,290 |
| Free Cash Flow | -$5,544 | $17,130 | -$4,880 | $447 |